Clinical Trials Logo

Filter by:
NCT ID: NCT00345982 Completed - Schizophrenia Clinical Trials

Augmenting Clozapine With Sertindole - SERCLOZ

Start date: September 2006
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether addition of sertindole to clozapine treatment can improve psychosis or the metabolic side-effects of clozapine in patients with treatment-resistant schizophrenia.

NCT ID: NCT00345735 Completed - Pain Clinical Trials

Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

Start date: May 2006
Phase: Phase 2
Study type: Interventional

Primary Objective: To demonstrate the efficacy of intranasal fentanyl in the treatment of breakthrough pain (BTP) in cancer patients. Secondary Objective: To explore the relationship between the response to the fentanyl dose and the stable background pain opioid dose.

NCT ID: NCT00345618 Completed - Thrombosis Clinical Trials

Clinical Study Assessing SSR126517E Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

CASSIOPEA
Start date: June 2006
Phase: Phase 3
Study type: Interventional

Objectives are to evaluate whether idrabiotaparinux (SSR126517E) is as least as effective as a standard warfarin treatment to prevent recurrence of venous thromboembolic events (VTE) in patients with symptomatic pulmonary embolism (PE) with or without symptomatic deep venous thrombosis (DVT) and to assess its safety (bleedings) versus warfarin.

NCT ID: NCT00345215 Completed - Healthy Humans Clinical Trials

The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans.

Start date: May 2006
Phase: N/A
Study type: Interventional

The aim of the study is to test the hypothesis that the function and/or regulation of aquaporin 2 and/or endothelial sodium channels in the principal cells of healthy humans is abnormal at high and low sodium intake

NCT ID: NCT00345202 Completed - Healthy Clinical Trials

Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

Start date: September 2004
Phase: Phase 4
Study type: Interventional

We wanted to test the shortterm effects of HMG-CoA reductase inhibition (atorvastatin) on renal hemodynamics, renal tubular function and vasoactive hormones on healthy subjects.

NCT ID: NCT00345124 Completed - Clinical trials for Essential Hypertension and Healthy Controls

The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension

Start date: May 2006
Phase: N/A
Study type: Interventional

The aim of the study is to test the following hypotheses: - that the function and/or regulation of AQP2 and/or ENaC in the principal cells is abnormal in essential hypertension. - if an abnormal function of the principal cells is present in essential hypertension, this will become more pronounced at high and low sodium intake.

NCT ID: NCT00344955 Completed - Healthy Clinical Trials

Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

Start date: January 2003
Phase: Phase 4
Study type: Interventional

We wanted to test the acute effect of HMG-CoA reductase inhibition (atorvastatin) on renal hemodynamics, renal tubular function and vasoactive hormones on healthy subjects.

NCT ID: NCT00344370 Completed - Dyslipidemia Clinical Trials

Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

Start date: August 2006
Phase: Phase 3
Study type: Interventional

This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.

NCT ID: NCT00344175 Completed - Clinical trials for Hypercholesterolemia

Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors

Start date: June 2006
Phase: Phase 3
Study type: Interventional

This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.

NCT ID: NCT00343343 Completed - Clinical trials for Diabetes Mellitus, Type 2

Comparison of NovoFine® Needles (4 mm vs. 6 mm)

Start date: June 2006
Phase: Phase 2
Study type: Interventional

This trial is conducted in Europe. The aim of this investigation is to explore the safety of a 4 mm needle compared to a 6 mm needle when injected in children and lean adults with diabetes.